Pages that link to "Q50537419"
Jump to navigation
Jump to search
The following pages link to Plasma levels of insulin-like growth factor-I and lung cancer risk: a case-control analysis (Q50537419):
Displaying 50 items.
- Smoking, green tea consumption, genetic polymorphisms in the insulin-like growth factors and lung cancer risk (Q21134792) (← links)
- PPAR-γ agonists and their effects on IGF-I receptor signaling: Implications for cancer (Q21328702) (← links)
- Unraveling insulin-like growth factor binding protein-3 actions in human disease (Q24650060) (← links)
- Implications of Insulin-like Growth Factor 1 Receptor Activation in Lung Cancer (Q26740210) (← links)
- Non-Alcoholic Fatty Liver Disease and Extra-Hepatic Cancers (Q26749045) (← links)
- Current perspectives between metabolic syndrome and cancer (Q26749299) (← links)
- A paradigm shift: Cancer therapy with peptide-based B-cell epitopes and peptide immunotherapeutics targeting multiple solid tumor types: Emerging concepts and validation of combination immunotherapy (Q26824462) (← links)
- Cancer chemoprevention by carotenoids (Q27011844) (← links)
- Mechanisms linking excess adiposity and carcinogenesis promotion (Q27022929) (← links)
- Is there a role for IGF-1 in the development of second primary cancers? (Q28069262) (← links)
- Insulin-like growth factor system in cancer: novel targeted therapies (Q28081603) (← links)
- Insulin-like growth factors (IGF-I, free IGF-I and IGF-II) and insulin-like growth factor binding proteins (IGFBP-2, IGFBP-3, IGFBP-6, and ALS) in blood circulation (Q28140279) (← links)
- Role of insulin-like growth factor binding protein-3 in breast cancer cell growth (Q28202893) (← links)
- Insulin-like growth factor (IGF)-I, IGF binding protein-3, and cancer risk: systematic review and meta-regression analysis (Q28258638) (← links)
- High expression levels of total IGF-1R and sensitivity of NSCLC cells in vitro to an anti-IGF-1R antibody (R1507) (Q28476277) (← links)
- IGFs and IGFBPs: surrogate markers for diagnosis and surveillance of tumour growth? (Q30320919) (← links)
- Activation of the insulin-like growth factor-1 receptor induces resistance to epidermal growth factor receptor antagonism in head and neck squamous carcinoma cells (Q30424348) (← links)
- Pre-operative factors that can predict neoplastic polypoid lesions of the gallbladder (Q30475370) (← links)
- Impaired glucose metabolism among those with and without diagnosed diabetes and mortality: a cohort study using Health Survey for England data (Q30912182) (← links)
- Insulin-like growth factor binding protein-6 activates programmed cell death in non-small cell lung cancer cells (Q33181042) (← links)
- Integrative genomic data mining for discovery of potential blood-borne biomarkers for early diagnosis of cancer (Q33382997) (← links)
- IGF-I induced genes in stromal fibroblasts predict the clinical outcome of breast and lung cancer patients (Q33522034) (← links)
- Serum IGF-I and C-reactive protein in healthy black and white young men: the CARDIA male hormone study (Q33559252) (← links)
- Transcriptional profiling of ErbB signalling in mammary luminal epithelial cells - interplay of ErbB and IGF1 signalling through IGFBP3 regulation (Q33692428) (← links)
- Insulin-like-growth-factor-binding-protein-3 (IGFBP-3) contrasts melanoma progression in vitro and in vivo (Q33721419) (← links)
- Insulin-like growth factor-I and cancer mortality in older men. (Q33738660) (← links)
- Lung cancer and hormone replacement therapy: association in the vitamins and lifestyle study (Q33770389) (← links)
- The ovarian cancer oncobiome (Q33829460) (← links)
- Role of insulin-like growth factors and their binding proteins in growth control and carcinogenesis (Q33853206) (← links)
- Development and validation of insulin-like growth factor-1 score to assess hepatic reserve in hepatocellular carcinoma (Q33859804) (← links)
- Estrogens and the pathophysiology of the biliary tree (Q33866800) (← links)
- Recent advances in cancer chemoprevention, with emphasis on breast and colorectal cancer (Q33890560) (← links)
- Insulin-like growth factor physiology and cancer risk (Q33959681) (← links)
- Insulin-like growth factors and risk of kidney cancer in men (Q34000274) (← links)
- The question of a link between insulin-like growth factor physiology and neoplasia (Q34030547) (← links)
- Klotho inhibits growth and promotes apoptosis in human lung cancer cell line A549. (Q34031303) (← links)
- Reactive oxygen metabolites can be used to differentiate malignant and non-malignant pleural efffusions (Q34094204) (← links)
- Fenretinide and cancer prevention (Q34107940) (← links)
- IGFBP-3, a marker of cellular senescence, is overexpressed in human papillomavirus-immortalized cervical cells and enhances IGF-1-induced mitogenesis (Q34151999) (← links)
- The reciprocal regulation of gamma-synuclein and IGF-I receptor expression creates a circuit that modulates IGF-I signaling. (Q34155259) (← links)
- Plasma levels of insulin-like growth factor-1 and insulin-like growth factor binding protein-3 in women with cervical neoplasia (Q34167065) (← links)
- The insulin-like growth factor system and cancer (Q34200058) (← links)
- Risk factors contributing to type 2 diabetes and recent advances in the treatment and prevention (Q34201551) (← links)
- The receptor tyrosine kinases: role in cancer progression. (Q34267620) (← links)
- Insulin-like growth factor I and prostate cancer (Q34303679) (← links)
- Energy balance, host-related factors, and cancer progression (Q34315762) (← links)
- Cancer risk following growth hormone use in childhood: implications for current practice (Q34320851) (← links)
- Growth hormone receptor antagonists: discovery and potential uses (Q34349411) (← links)
- Increased risk of cancer in patients with type 2 diabetes mellitus: a retrospective cohort study in China (Q34354362) (← links)
- Insulin-like growth factor receptor 1 (IGF1R) expression and survival in non-small cell lung cancer patients: a meta-analysis. (Q34501591) (← links)